How Tech is Transforming the Cannabis Sector

LONDON, December 19, 2018 /PRNewswire/ --

So far, a few big hitters have gotten all the attention in the marijuana boom, riding the Green Wave to double-digit growth during 2018. But a much smaller company is about to make a huge impact. Mentioned in today's commentary includes: The Supreme Cannabis Company, Inc. (OTC:SPRWF) (TSX.V:FIRE), MedMen Enterprises Inc. (OTC:MMNFF) (CSE:MMEN), Aphria (NYSE:APHA) (TSX:APHA), The Green Organic Dutchman (OTC:TGODF) (TSX:TGOD), Molson Coors (NYSE:TAP) (TSX:TPX-A).

Wayland Group (WAYL [ ] , MRRCF [ ]) is a vertically-integrated cannabis producer. Like the other heavy hitters of the industry, such as Cronos Group and Canopy Growth Corp., Wayland focuses on cultivating cannabis for delivery to markets around the world. But Wayland has a secret. While Cronos and Canopy get all the attention, Wayland has been quietly perfecting production methods that are aiming to be the most efficient in the world.

By harnessing cutting edge tech, including the latest advancements in AI and automation, Wayland have cut the costs of cultivation down so low their gross margins are forecast to be staggering. This makes Wayland the biggest un-told story in the business.

Harnessing superior tech to beat out the competition is the reason this company aims to become the most profitable in Cannabis. And Wayland Group, by focusing on efficiency first and foremost, is aiming to pull off a Cannabis 2.0 miracle of its own. #1 Huge Potential Profit in a $150 Billion Market by 2025  

From their main production center in Canada, Wayland (WAYL [ ], MRRCF [ ]) can produce cannabis for 60 cents per gram, and 5 cents per gram in Latin America. Wayland can sell the same type of product to EU markets where it sells for C$16 per gram. And with the global medical cannabis market projected to be $150 billion by 2025 [ ], the potential for future profit is immense.

Wayland has global reach. It can produce in North America and Europe, has just signed contracts to take over assets in Latin America, and can move product to markets around the world. #2 How They Do It 

There are four keys to Wayland's (WAYL [ ], MRRCF [ ]) highly profitable business plans:

1) Operational Efficiency: They Only Use a fraction of the Staff Traditional Growers Need 

Wayland collects every scrap of data from its cultivation process and feeds it into an Artificially Intelligent Master Grower. The company's Canadian growing facilities require a staff of only 26 people-compared to the 500 or so needed to run the operations of some other big-time producers. That's a fraction of the staff that traditional growers need... and it keeps production costs down.

2) Automation Efficiency: Partnership with Rockwell Automation 

The AI Master Grower is powered by Rockwell Automation, and Wayland is the first cannabis company to embrace automation as a key feature of the cultivation process. With a tiny staff of 26 employees, Wayland can run an entire complex capable of producing thousands of grams of cannabis for export. That brings production costs way, way down. At the Langton facility in Canada, Wayland deploys the AI Master Grower to oversee 365,000 square feet and a potential annual capacity of 65,000 kilos.

3) Energy Efficiency: 88%-To-Net-Zero 

Their facilities are powered by natural gas co-generation, and they utilize recycled water for their hydroponics, which cuts down on waste that can accumulate from bad growth practices. The Langton facility has been categorized as "88-percent-to-net-zero," meaning that it doesn't have to rely much on external sources of water and power. A natural gas well on-site means electric charges have been reduced from $0.20/kilowatt hour to $0.05/kilowatt hour.

4) Technological Breakthroughs: Improving Profit Margins 

Wayland has deployed VESIsorb [ ] medical tech for its cannabis products. When cannabinoids are ingested, they enter the body but tend to get clumped in the digestive system, interfering with absorption and diminishing the overall effect. VESIsorb disperses the CBD molecules so they're easier to absorb, providing higher and more immediate levels of CBD absorption.

#3 From Zero to 95,000,000 Grams in 2020? 

Wayland is planning to step up production as we head in to 2019. Thanks to mass automation, the company believes it can quickly ramp up output: from just 2,400 kilos in 2018, Wayland intends to be producing 36,000 kilos in 2019, and within a year that figure is planned to climb to 95,000 kilos. And that's just from the company's Canadian facilities.

In Switzerland, Wayland plans to soon be producing 14,000 kilos of CBD product, and another 120,000 kilos out of Germany. When concentrated, all that output results in about 15,000 kilos of CBD isolate.

Global demand could be as high as $150 billion by 2025. The customer base for medical marijuana has grown by leaps and bounds.

#4 One of Only 5 in the World 

Wayland has a big head-start over other potential competitors. It's an approved GMP certified producer in the EU, one of only five, along with Canopy Growth Corp., Cronos Group, Tilray and Aurora. Of those five companies, Wayland is the only one not trading above a $5 billion market cap.

Instead, Wayland is still relatively small. Its market cap is around $250 million, but its potential output and its profit margins should make it a very worthy competitor to many of its larger rivals.

#5 From $4 Million to $100 Million in 2019 

Right now, Wayland's (WAYL [ ], MRRCF [ ]) revenue stream is small: only about $4 million. But from $4 million this year, Wayland expects to bring enough product to market to realize $100 million in sales next year.

While Canopy, Tilray and Cronos Group got big fast, Wayland is taking its time. And investors have already started to notice. In 2019, cannabis will enter the mainstream. Demand is set to grow. And Wayland's low production costs will give it an edge over its competitors. Other cannabis stocks investors are watching closely:  

The Supreme Cannabis Company, Inc. (OTCQX:SPRWF) (TSX.V:FIRE)

Recently, Supreme announced an international partnership with Khalifa Kush, a brand run by rapper Wiz Khalifa.

Wiz Khalifa noted [ ], "My team and I have spent the past year finding a partner that shares our vision, values and passion for cannabis. The team at Supreme Cannabis understands the importance of high quality cannabis and how to produce high quality cannabis at scale."

MedMen Enterprises Inc. (OTCQX:MMNFF) (CSE:MMEN)

The company announced a 50/50 joint venture, MedMen Canada, with Canadian-based Cronos Group, the first ever marijuana firm to be listed on the Nasdaq. Its IPO proved somewhat disappointing, with the stock price falling shortly after the initial wave of enthusiasm dropped off. But the company has still managed to raise over $100 million since 2017.

Recently, MedMen announced [ ] the closing of yet another acquisition, bringing its total licensed-and-operational assets to 70, spread across 12 U.S. states.


Aphria is a Canada-based cannabis company which focuses on the production, sales, and distribution of legal marijuana. The company's business model focuses primarily on online sales, which is perfect for its patients.

In a recent press release, the company announced a supply agreement to provide medical marijuana in Paraguay. "Latin America continues to represent an important growth opportunity within the global medical cannabis industry, and we are excited to be among the first to enter the rapidly emerging market in Paraguay," Aphria President Jakob Ripshtein explained [ ] .

The Green Organic Dutchman (OTCQX:TGODF) (TSX:TGOD)

Recently, the Canada-based Dutchman announced a pivotal distribution partnership with HelloMD, a leading online medicinal cannabis company.

Andrew Pollock, Vice President of Marketing at the Dutchman, explained [ ], "Patients deserve premium organic cannabis and through the partnership with HelloMD, we are pleased to provide increased access to TGOD's product lines with the highest level of customer service and functionality to our patients."

Molson Coors (NYSE:TAP) (TSX:TPX-A)

Not to be left behind in the marijuana boom, Molson Coors is also developing a line of non-alcoholic cannabis-based beverages with its partner, the Hydropothecary Corporation.

Molson Coors Canada president and CEO Frederic Landtmeters noted [ ] , "While we remain a beer business at our core, we are excited to create a separate new venture with a trusted partner that will be a market leader in offering Canadian consumers new experiences with quality, reliable and consistent non-alcoholic, cannabis-infused beverages."


Notice for Forward-Looking Information

Certain statements in this press release are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such forward-looking information includes that cannabis use and sales will grow as currently predicted; Wayland's intended acquisition of various foreign companies and expansion into international markets; Wayland's plans to bring automation and the latest technology to projects in various locations throughout the world; that it could be granted growing licenses; that Wayland can close on its announced purchases and joint ventures; that through efficiency and technology Wayland can substantially lower its production costs below competitors; that Wayland can sell its product at huge gross margins; that Wayland will create a range of cannabis consumer brands, to be distributed through their own digital platforms and retail facilities; that Wayland can successfully integrate pharmaceutical breakthroughs into its products; that Wayland can achieve its sales targets and gross profit margins as planned; and that it will be able to carry out its business plans.

Readers are cautioned to not place undue reliance on forward-looking information. Forward looking information is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from those contemplated in the forward-looking information, and even if such actual results or events are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Wayland. Such risks and uncertainties include, among other things: that a regulatory approval that may be required for the intended acquisitions and subsequent sales are not obtained or are obtained subject to conditions that are not anticipated; growing competition for intended acquisitions in the cannabis industry; announced or expected acquisitions or joint ventures may not close because of inability to come to final terms, or inability to obtain regulatory compliance; potential future competition in the markets Wayland operates for sales; competitors may quickly enter the industry; general economic conditions in the US, Canada and globally; the inability to secure financing necessary to carry out its business plans; competition for, among other things, capital and skilled personnel; the possibility that government policies or laws may not permit legal cannabis sales or growth or that favorable laws in place may change; interruption or failure of information or other technology systems; the cannabis market may not grow as expected; Wayland's technology and drive for efficiency may not achieve the expected results and its accomplishments may be limited; Wayland may not successfully develop a cannabis consumer brand; and it may not be successful in developing a cannabis based treatment for medical uses; even if it develops a successful treatment, it may not be able to protect its intellectual property; its patent applications may be rejected or successfully challenged; Wayland's business plan also carries risk, including its ability to comply with all applicable governmental regulations in a highly regulated business; incubator risk investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal laws; and regulatory risks relating to Wayland's business, financings and strategic acquisitions.


PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buy or sell securities., Leacap Ltd, and their owners, managers, employees, and assigns (collectively "the Company") has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by Wayland fifty-eight thousand three hundred thirty three US dollars for this article and certain banner ads. This compensation is a major conflict with our ability to be unbiased, more specifically:

This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in our newsletter and on our website may be based on end-of- day or intraday data. We have been compensated by Wayland to conduct investor awareness advertising and marketing for Wayland. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the company. The third party, profiled company, or their affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our alerts experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public and non-public sources but is not researched or verified in any way whatsoever to ensure the information is correct.

SHARE OWNERSHIP. The owner of will not notify the market when it decides to buy or sell shares of this issuer in the market. The owner of will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

NOT AN INVESTMENT ADVISOR. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities.

DISCLAIMER: is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with or any company mentioned herein. The commentary, views and opinions expressed in this release by are solely those of and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.


This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.


        Contact Information: 
        Media Contact - FN Media Group LLC 
        U.S. Phone: +1(954)345-0611